Published online Sep 6, 2021. doi: 10.12998/wjcc.v9.i25.7292
Peer-review started: March 17, 2021
First decision: May 5, 2021
Revised: May 12, 2021
Accepted: August 5, 2021
Article in press: August 5, 2021
Published online: September 6, 2021
Processing time: 166 Days and 14.3 Hours
Radiation therapy (RT) is considered one of the cornerstone modalities of treatment for different cancer types. The preparation and delivery of RT requires a number of staff members from different disciplines within the radiation oncology department. Since the emergence of the corona virus disease 2019 (COVID-19) pandemic, RT, similar to other cancer care modalities, has been adapted to minimize patient and staff exposure without compromising the oncological outcomes. This was reflected in the dramatic practice changes that occurred in the past year to address the lockdown restrictions and fulfill the infection control requirements. RT practices differ across regions based on financial and training levels, and developing countries with limited resources have struggled to maintain radiation treatment services at a level equivalent to that in developed countries while following pandemic control guidelines. The response during the COVID-19 pandemic varied between developing countries according to the infection rate and RT technological capabilities. In this editorial, we review recently published articles addressing radiotherapy practice reports during the COVID-19 pandemic in developing countries.
Core Tip: This editorial discusses the impact of corona virus disease 2019 (COVID-19) pandemic on radiation oncology practice in developing countries. The challenges and measures taken to mitigate COVID19 and its ramifications.